BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7803644)

  • 1. Clinical manifestations of genital infection due to Chlamydia trachomatis in women: differences related to serovar.
    Workowski KA; Stevens CE; Suchland RJ; Holmes KK; Eschenbach DA; Pettinger MB; Stamm WE
    Clin Infect Dis; 1994 Oct; 19(4):756-60. PubMed ID: 7803644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic.
    Magder LS; Harrison HR; Ehret JM; Anderson TS; Judson FN
    Am J Epidemiol; 1988 Aug; 128(2):298-308. PubMed ID: 3394697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel markers for uncomplicated lower genital tract infections and upper genital tract pathology due to Chlamydia trachomatis.
    Collet T; Macnaughton T; Walsh T; Debattista J; Timms P
    Int J Infect Dis; 2011 Apr; 15(4):e257-66. PubMed ID: 21295509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of evidence of a relationship between genital symptoms, cervicitis and salpingitis and different serovars of Chlamydia trachomatis.
    Persson K; Osser S
    Eur J Clin Microbiol Infect Dis; 1993 Mar; 12(3):195-9. PubMed ID: 8508818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genital Chlamydia trachomatis (serotypes D-K) infection in Jamaican commercial street sex workers.
    Dowe G; King SD; Brathwaite AR; Wynter Z; Chout R
    Genitourin Med; 1997 Oct; 73(5):362-4. PubMed ID: 9534744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of serovar to clinical manifestations of urogenital Chlamydia trachomatis infection.
    Geisler WM; Suchland RJ; Whittington WL; Stamm WE
    Sex Transm Dis; 2003 Feb; 30(2):160-5. PubMed ID: 12567176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silent upper genital tract chlamydial infection and disease in women.
    Tait IA; Duthie SJ; Taylor-Robinson D
    Int J STD AIDS; 1997 May; 8(5):329-31. PubMed ID: 9175656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of serology, antibiotic susceptibility testing and serovar determination in genital chlamydial infections.
    Persson K
    Best Pract Res Clin Obstet Gynaecol; 2002 Dec; 16(6):801-14. PubMed ID: 12473283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease.
    Wiesenfeld HC; Hillier SL; Krohn MA; Amortegui AJ; Heine RP; Landers DV; Sweet RL
    Obstet Gynecol; 2002 Sep; 100(3):456-63. PubMed ID: 12220764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Chlamydia trachomatis serovars causing rectal and cervical infections.
    Barnes RC; Rompalo AM; Stamm WE
    J Infect Dis; 1987 Dec; 156(6):953-8. PubMed ID: 3680995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of genital infection with specific Chlamydia trachomatis serovars and race.
    Workowski KA; Suchland RJ; Pettinger MB; Stamm WE
    J Infect Dis; 1992 Dec; 166(6):1445-9. PubMed ID: 1431263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibilities of Chlamydia trachomatis isolates causing uncomplicated female genital tract infections and pelvic inflammatory disease.
    Rice RJ; Bhullar V; Mitchell SH; Bullard J; Knapp JS
    Antimicrob Agents Chemother; 1995 Mar; 39(3):760-2. PubMed ID: 7793888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in clinical manifestations of genital chlamydial infections related to serovars.
    van de Laar MJ; van Duynhoven YT; Fennema JS; Ossewaarde JM; van den Brule AJ; van Doornum GJ; Coutinho RA; van den Hoek JA
    Genitourin Med; 1996 Aug; 72(4):261-5. PubMed ID: 8976830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genital infections with Chlamydia trachomatis and Neisseria gonorrhoeae in Ghanaian women.
    Bentsi C; Klufio CA; Perine PL; Bell TA; Cles LD; Koester CM; Wang SP
    Genitourin Med; 1985 Feb; 61(1):48-50. PubMed ID: 3936773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical manifestations and epidemiology of the new genetic variant of Chlamydia trachomatis.
    Bjartling C; Osser S; Johnsson A; Persson K
    Sex Transm Dis; 2009 Sep; 36(9):529-35. PubMed ID: 19617866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection.
    Ito JI; Lyons JM; Airo-Brown LP
    Infect Immun; 1990 Jun; 58(6):2021-3. PubMed ID: 2341189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative culture of Chlamydia trachomatis: relationship of inclusion-forming units produced in culture to clinical manifestations and acute inflammation in urogenital disease.
    Geisler WM; Suchland RJ; Whittington WL; Stamm WE
    J Infect Dis; 2001 Nov; 184(10):1350-4. PubMed ID: 11679929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of infecting serovar and local inflammation in genital chlamydial infections.
    Batteiger BE; Lennington W; Newhall WJ; Katz BP; Morrison HT; Jones RB
    J Infect Dis; 1989 Aug; 160(2):332-6. PubMed ID: 2760488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydia trachomatis in sexually active teenage girls. Factors related to genital chlamydial infection: a prospective study.
    Rahm VA; Odlind V; Pettersson R
    Genitourin Med; 1991 Aug; 67(4):317-21. PubMed ID: 1916795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlamydia trachomatis infection of the female genital tract. Pathogenetic and clinicopathologic correlations.
    Winkler B; Crum CP
    Pathol Annu; 1987; 22 Pt 1():193-223. PubMed ID: 3554120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.